|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.00 GBX | -1.12% |
|
+16.10% | +9.73% |
| 29/07 | Essentra plc, H1 2026 Earnings Call, Jul 28, 2026 | |
| 28/07 | EARNINGS AND TRADING: Allergy Therapeutics names next executive chair | AN |
Company Valuation: Essentra plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,038 | 712 | 488.3 | 381.3 | 275 | 304 | - | - |
| Change | - | -31.4% | -31.42% | -21.91% | -27.87% | 10.53% | - | - |
| Enterprise Value (EV) 1 | 1,273 | 598.2 | 550.8 | 449.5 | 335.7 | 399.3 | 389 | 378.9 |
| Change | - | -52.99% | -7.92% | -18.39% | -25.31% | 18.93% | -2.58% | -2.58% |
| P/E | 38.8x | -3.79x | 94.2x | 35.9x | 138x | 126x | 24.1x | 17.7x |
| PBR | 1.7x | 0.88x | 1.79x | 1.42x | 1.05x | 1.2x | 1.13x | 1.1x |
| PEG | - | 0x | -1x | 0x | -1.7x | 5.9x | 0x | 0.5x |
| Capitalization / Revenue | 1.08x | 2.11x | 1.54x | 1.26x | 0.91x | 0.94x | 0.92x | 0.88x |
| EV / Revenue | 1.33x | 1.77x | 1.74x | 1.49x | 1.11x | 1.23x | 1.17x | 1.09x |
| EV / EBITDA | 9.42x | 5.01x | 8.78x | 7.75x | 6.73x | 7.56x | 6.87x | 6.14x |
| EV / EBIT | 15.1x | 23.8x | 12.8x | 11.2x | 10.5x | 11.8x | 10.1x | 8.76x |
| EV / FCF | 51.5x | 24.6x | 32.2x | 32.6x | 22.7x | 20.8x | 18.6x | 17x |
| FCF Yield | 1.94% | 4.06% | 3.1% | 3.07% | 4.41% | 4.8% | 5.37% | 5.89% |
| Dividend per Share 2 | 0.06 | 0.033 | 0.036 | 0.043 | 0.034 | 0.0231 | 0.0254 | 0.0295 |
| Rate of return | 1.74% | 1.4% | 2.12% | 3.23% | 3.52% | 2.15% | 2.36% | 2.76% |
| EPS 2 | 0.089 | -0.624 | 0.018 | 0.037 | 0.007 | 0.0085 | 0.0445 | 0.0607 |
| Distribution rate | 67.4% | -5.29% | 200% | 116% | 486% | 272% | 57% | 48.7% |
| Net sales 1 | 959.7 | 337.9 | 316.3 | 302.4 | 302 | 325 | 331.8 | 346.7 |
| EBITDA 1 | 135.1 | 119.5 | 62.7 | 58 | 49.9 | 52.79 | 56.66 | 61.72 |
| EBIT 1 | 84 | 25.1 | 43.2 | 40.1 | 32 | 33.95 | 38.47 | 43.25 |
| Net income 1 | 26.9 | -183.8 | 5.4 | 10.6 | 2.1 | 2.2 | 13.39 | 16.67 |
| Net Debt 1 | 234.7 | -113.8 | 62.5 | 68.2 | 60.7 | 95.27 | 84.97 | 74.92 |
| Reference price 2 | 3.450 | 2.365 | 1.696 | 1.330 | 0.966 | 1.072 | 1.072 | 1.072 |
| Nbr of stocks (in thousands) | 300,821 | 301,047 | 287,918 | 286,708 | 284,712 | 283,587 | - | - |
| Announcement Date | 18/3/22 | 29/3/23 | 19/3/24 | 19/3/25 | 17/3/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 126.12x | 1.23x | 7.56x | 2.15% | 404M | |
| 15.84x | - | - | - | 14.47B | |
| 22.38x | 2.79x | 12.2x | 2.04% | 9.62B | |
| 270.45x | 57.89x | 194.25x | 0.13% | 7.68B | |
| 19.45x | 1.76x | 10.34x | 2.1% | 6.35B | |
| 22.36x | 2.09x | 9.29x | -.--% | 6.33B | |
| 82.32x | 26.79x | 67.68x | 0.27% | 5.67B | |
| 34.81x | 3.65x | 16.91x | 0.98% | 3.17B | |
| 86.69x | 6.75x | 30.07x | 0.44% | 3.14B | |
| 18.9x | - | - | - | 2.41B | |
| Average | 69.93x | 12.87x | 43.54x | 1.02% | 5.92B | |
| Weighted average by Cap. | 63.01x | 16.07x | 53.55x | 0.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ESNT Stock
- Valuation Essentra plc
Select your edition
All financial news and data tailored to specific country editions
